DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Steve Hanke - 2 dollarization - 1 Javier Milei's - 1
Top related locs:
U.S
Top related orgs:
John Hopkins University - 2 Argentina - 1

Search resuls for: "John Hopkins University"


4 mentions found


☆ Argentina: Steve Hanke says many arguments against dollarization are 'absolute rubbish'
  + stars: | 2023-11-20 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailArgentina: Steve Hanke says many arguments against dollarization are 'absolute rubbish'Steve Hanke, professor of applied economics at John Hopkins University, discusses the possible implications that libertarian Javier Milei's victory in Argentina's presidential runoff contest may have for the peso.
Persons: Steve Hanke, dollarization, Javier Milei's Organizations: Argentina, John Hopkins University
☆ Steve Hanke expects a recession in the U.S. next year as money supply contracts
  + stars: | 2023-09-04 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSteve Hanke expects a recession in the U.S. next year as money supply contractsSteve Hanke, professor of applied economics at John Hopkins University, says the Fed is looking at lagging indicators, adding that he does not believe that the U.S economy is on track for a "soft landing."
Persons: Steve Hanke Organizations: John Hopkins University Locations: U.S
☆ After weight loss, Alzheimer's may be next frontier for drugs like Ozempic
  + stars: | 2023-05-08 | by ( Natalie Grover | ) www.reuters.com   time to read: +6 min
LONDON, May 8 (Reuters) - Diabetes drugs that also promote weight loss such as Novo Nordisk’s (NOVOb.CO) Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Those successes followed decades of futility that had left many questioning the validity of the amyloid theory behind most experimental Alzheimer's drugs. She said she has since been approached by pharmaceutical companies at an increasing pace, and is currently running an Alzheimer’s trial evaluating intranasal insulin in combination with another diabetes drug. Four companies with GLP-1 drugs, including two larger drugmakers, say they are watching for results of trials testing Novo's drug in Alzheimer's. Dementia affects more than 55 million people globally and the market for Alzheimer’s drugs is expected to grow to $9.4 billion by 2028 and for Parkinson’s to $6.6 billion, according to pharmaceutical data provider Citeline.
☆ Fact Check-‘Catastrophic Contagion’ video is fictional and does not support claims about pandemic preparedness exercises
  + stars: | 2022-12-15 | by ( Reuters Fact Check | ) www.reuters.com   time to read: +6 min
Baseless claims that pandemic preparedness exercises are proof that disease outbreaks are “planned” by authorities have been a recurring narrative since the coronavirus pandemic broke out. These fictional scenarios go beyond infectious diseases, as such exercises also exist for natural disasters or nuclear events, for example. These rules, that are binding for WHO members, set out countries’ obligations when handling public health events and emergencies that could potentially cross borders (here) (here). Otherwise, we will be unprepared for the next infectious disease event. Experts told Reuters that preparedness exercises like “Catastrophic Contagion” have been a part of pandemic preparedness for at least the last two decades.
0 next >>
Total: 4